Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Diabetes Monitoring Using Smart Device, 4341 [2014-01440]

Download as PDF Federal Register / Vol. 79, No. 17 / Monday, January 27, 2014 / Notices DEPARTMENT OF DEFENSE Department of the Army Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Protective Clothing Ensemble with Two-Stage Evaporative Cooling Department of the Army, DoD. ACTION: Notice. AGENCY: Announcement is made of the availability for licensing of the invention set forth in U.S. Patent Application Serial No. 13/782,132, entitled ‘‘Protective Clothing Ensemble with Two-Stage Evaporative Cooling,’’ filed on March 1, 2013. The United States Government, as represented by the Secretary of the Army, has rights to this invention. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702– 5012. FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619–6664, both at telefax (301) 619–5034. SUPPLEMENTARY INFORMATION: The invention relates to a hazardous materials protective garment that may use a two-stage evaporative cooling process to ease heat strain on the wearer of the garment. SUMMARY: Brenda S. Bowen, Army Federal Register Liaison Officer. BILLING CODE 3710–08–P DEPARTMENT OF DEFENSE Department of the Army Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Tamper Evident Directed Inventory and Accountability Technology Department of the Army, DoD. Notice. AGENCY: mstockstill on DSK4VPTVN1PROD with NOTICES Announcement is made of the availability for licensing of the invention set forth in U.S. Patent Application Serial No. 13/814,600, entitled ‘‘Tamper Evident Directed Inventory and Accountability Technology,’’ filed on February 6, 2013. The United States Government, as SUMMARY: VerDate Mar<15>2010 18:16 Jan 24, 2014 Jkt 232001 For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619–6664, both at telefax (301) 619–5034. SUPPLEMENTARY INFORMATION: The invention relates to a plastic or glass vial or container with an embedded data storage mechanism, such as radio frequency identification tags (RFID) or similar integrated circuit technology, capable of receiving and storing data, as well as transmitting data when queried. FOR FURTHER INFORMATION CONTACT: a diabetes care provider including wirelessly transmitting diabetes readings from at least one diabetes device via a patient’s smart device to a diabetes care provider’s smart device through a secure server. Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2014–01440 Filed 1–24–14; 8:45 am] BILLING CODE 3710–08–P DEPARTMENT OF DEFENSE Department of the Army Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Plasmodium Falciparum Circumsporozoite Vaccine Gene Optimization for Soluble Protein Expression Brenda S. Bowen, Army Federal Register Liaison Officer. AGENCY: [FR Doc. 2014–01442 Filed 1–24–14; 8:45 am] ACTION: Department of the Army, DoD. Notice. BILLING CODE 3710–08–P AGENCY: Announcement is made of the availability for licensing of the invention set forth in U.S. Patent Application Serial No. 13/880,227, entitled ‘‘Plasmodium Falciparum Circumsporozoite Vaccine Gene Optimization for Soluble Protein Expression,’’ filed on June 11, 2013. The United States Government, as represented by the Secretary of the Army, has rights to this invention. ACTION: ADDRESSES: SUMMARY: DEPARTMENT OF DEFENSE Department of the Army Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Diabetes Monitoring Using Smart Device Department of the Army, DoD. Notice. Announcement is made of the availability for licensing of the invention set forth in U.S. Patent Application Serial No. 13/911,137, entitled ‘‘Diabetes Monitoring Using Smart Device,’’ filed on June 6, 2013. The United States Government, as represented by the Secretary of the Army, has rights to this invention. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702– 5012. SUMMARY: [FR Doc. 2014–01438 Filed 1–24–14; 8:45 am] ACTION: represented by the Secretary of the Army, has rights to this invention. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702– 5012. 4341 For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619–6664, both at telefax (301) 619–5034. SUPPLEMENTARY INFORMATION: The invention relates to a method for communicating diabetes information to FOR FURTHER INFORMATION CONTACT: PO 00000 Frm 00021 Fmt 4703 Sfmt 9990 Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702– 5012. For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619–6664, both at telefax (301) 619–5034. FOR FURTHER INFORMATION CONTACT: The invention relates to a method to produce vaccine grade, highly immunogenic and near full-length CSP of P. falciparum in E. coli. SUPPLEMENTARY INFORMATION: Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2014–01441 Filed 1–24–14; 8:45 am] BILLING CODE 3710–08–P E:\FR\FM\27JAN1.SGM 27JAN1

Agencies

[Federal Register Volume 79, Number 17 (Monday, January 27, 2014)]
[Notices]
[Page 4341]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-01440]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Notice of Availability for Exclusive, Non-Exclusive, or 
Partially-Exclusive Licensing of an Invention Concerning Diabetes 
Monitoring Using Smart Device

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Announcement is made of the availability for licensing of the 
invention set forth in U.S. Patent Application Serial No. 13/911,137, 
entitled ``Diabetes Monitoring Using Smart Device,'' filed on June 6, 
2013. The United States Government, as represented by the Secretary of 
the Army, has rights to this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research and Technology Applications (ORTA), (301) 619-
6664, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates to a method for 
communicating diabetes information to a diabetes care provider 
including wirelessly transmitting diabetes readings from at least one 
diabetes device via a patient's smart device to a diabetes care 
provider's smart device through a secure server.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2014-01440 Filed 1-24-14; 8:45 am]
BILLING CODE 3710-08-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.